Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,201 | -16,915 | N/A | N/A | N/A |
| Depreciation Amortization | 25,818 | 23,845 | N/A | N/A | N/A |
| Income taxes - deferred | -1,159 | 317 | N/A | N/A | N/A |
| Accounts receivable | -1,888 | -4,146 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,470 | -871 | N/A | N/A | N/A |
| Other Working Capital | 2,290 | -15,841 | N/A | N/A | N/A |
| Other Operating Activity | 1,785 | 13,425 | 0 | 0 | 0 |
| Operating Cash Flow | $24,115 | $-186 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,148 | -3,541 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -70 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 90 | 0 | 0 | 0 |
| Investing Cash Flow | $-17,148 | $-3,451 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 310,630 | N/A | N/A | N/A |
| Debt Repayment | -2,640 | -255,202 | N/A | N/A | N/A |
| Common Stock Repurchased | -227 | -9 | N/A | N/A | N/A |
| Dividend Paid | N/A | -52,056 | N/A | N/A | N/A |
| Other Financing Activity | -1,300 | -12,530 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,167 | $-9,167 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 34 | -69 | N/A | N/A | N/A |
| Beginning Cash Position | 21,866 | 34,739 | N/A | N/A | N/A |
| End Cash Position | 24,700 | 21,866 | N/A | N/A | N/A |
| Net Cash Flow | $2,834 | $-12,873 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,115 | -186 | N/A | N/A | N/A |
| Capital Expenditure | -17,148 | -3,541 | N/A | N/A | N/A |
| Free Cash Flow | 6,967 | -3,727 | 0 | 0 | 0 |